Nautilus Biotechnology, Inc. (NAUT) Institutional Ownership

Ownership Summary

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) has 68 institutional investors that have filed 13F reports for the period ending December 2025.

• Their combined ownership stood at 46.2% of outstanding shares in December 2025, up from 45.8% in September 2025.
• They increased total shares held in Nautilus Biotechnology by 1.98% from last quarter, and the number of investors in NAUT decreased 24.44% annually.
• Of these 68 holders, 30 added to their stakes in Nautilus Biotechnology, 14 trimmed positions, and 24 made no changes.
• Combined, these investors held 58.41Mn shares in NAUT for December 2025, up by 1.13Mn shares quarter on quarter, and down 5.96Mn shares year over year.
• HILLMAN CO holds the largest position in NAUT at 200.0K shares as of December 31, 2025, or 0.16% of shares outstanding.
• The biggest buyers of Nautilus Biotechnology for the quarter ending December 2025 included GILL CAPITAL PARTNERS, LLC (250).
• Business Quant data shows the 6 biggest positions in Nautilus Biotechnology as of December 2025 are held by HILLMAN CO (200.0K), Presidio Capital Management, LLC (34.66K), Badgley Phelps Wealth Managers, LLC (30.0K), FNY Investment Advisers, LLC (14.0K), Vanguard Capital Wealth Advisors (13.0K), GILL CAPITAL PARTNERS, LLC (250).